A2aR checkpoint inhibitor (Hanmi)

N/A

Report date: 2025/01/26 18:05:01
NME

Base Information

Drug NameA2aR checkpoint inhibitor (Hanmi)
Drug Alias NameADOR antagonist (Hanmi)adenosine 2A receptor checkpoint inhibitor (Hanmi)HM-87086
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor antagonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A